Get startedLog in
    Picture of Roche Holding AG logo

    ROP — Roche Holding AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Roche Says Receives FDA Approval For The First Companion Diagnostic To Assess PTEN Protein In People Living With Prostate Cancer

    Picture of Roche Holding AG logoRoche Holding AG
    12/06/2026 20:16
    BRIEF-Roche Says Receives FDA Approval For The First Companion Diagnostic To Assess PTEN Protein In People Living With Prostate Cancer
    June 12 (Reuters) - Roche Holding AG ROPC.S:
    • ROCHE RECEIVES FDA APPROVAL FOR THE FIRST COMPANION DIAGNOSTIC TO ASSESS PTEN PROTEIN IN PEOPLE LIVING WITH PROSTATE CANCER
    Source text: ID:nGNE8DNhWr
    Further company coverage: ROPC.S

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Roche Holding AG

    See all news